| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fd15d8ebb22202b5cfe2b109cd922c5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5db7b0b72a2f182541ab0bec36d62c55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33414d4b140a882e29a34227a6933b12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b49677a845243272aecf9a10c829533e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ada52f30e40ed58b54f9c1d73bb1348
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a716e5c250d7a6af0357f4b5c18aa0ca |
| publicationDate |
2015-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20150102595-A |
| titleOfInvention |
MTA3, a marker for predicting the response to anti-cancer drug in a patient with ovarian cancer |
| abstract |
The present invention relates to a composition, a kit, and a method for predicting the response of an ovarian cancer patient to chemotherapeutic treatment by detecting the methylation level or MTA3 expression level of the CpG region of MTA3 (Metastasis Associated Family, Member 3) gene. |
| priorityDate |
2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |